Company Filing History:
Years Active: 2008
Title: Scott Young - Innovator in Hypertension Treatment
Introduction
Scott Young is a notable inventor based in Stowe, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of hypertension. His innovative approach focuses on improving patient outcomes through the use of specific pharmaceutical agents.
Latest Patents
Scott Young holds a patent for a method titled "Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents." This invention provides a method of using anti-hypertensive agents (AHAs) to mitigate the transient increase in blood pressure observed in patients receiving vascular targeting agents (VTAs) for diseases associated with malignant neovascularization. The patent also encompasses pharmaceutical compositions that include both AHAs and VTAs, as well as related kits.
Career Highlights
Scott is associated with Oxigene, Inc., a company dedicated to advancing cancer therapies. His work at Oxigene has allowed him to focus on innovative solutions that address critical health challenges.
Collaborations
One of his notable coworkers is David J Chaplin, with whom he has likely collaborated on various projects aimed at enhancing treatment methodologies.
Conclusion
Scott Young's contributions to hypertension treatment through his patented methods exemplify the impact of innovation in medicine. His work continues to pave the way for improved therapeutic strategies in managing complex health conditions.